Adaptive Biotechnologies Corporation Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 70.9M | 71.7M | 94.0M | 58.9M | 52.4M | 47.5M | 46.4M | 43.2M |
| Cost of Goods Sold | 18.7M | 18.2M | 18.2M | 18.0M | 17.0M | 18.0M | 16.7M | 19.3M |
| Gross Profit | 52.2M | 53.5M | 75.8M | 40.9M | 35.5M | 29.4M | 29.8M | 23.9M |
| R&D Expenses | 23.6M | 21.8M | 23.7M | 24.1M | 24.2M | 23.2M | 24.2M | 25.4M |
| Operating Expenses | 71.4M | 66.2M | 65.5M | 65.9M | 65.1M | 63.3M | 62.4M | 71.2M |
| Operating Income | -19.2M | -12.8M | 10.3M | -25.0M | -29.6M | -33.8M | -32.6M | -47.3M |
| Other Income / Gains | -827K | -806K | -744K | -557K | -248K | 120K | 561K | 1.1M |
| Net Income | -20.0M | -13.6M | 9.5M | -25.6M | -29.9M | -33.7M | -32.1M | -46.2M |
| EPS (Diluted) | -0.13 | -0.09 | 0.063 | -0.17 | -0.20 | -0.23 | -0.22 | -0.31 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.736 | 0.746 | 0.807 | 0.694 | 0.676 | 0.62 | 0.641 | 0.553 |
| General And Administrative Expenses | 21.0M | 19.6M | 18.0M | 17.8M | 17.4M | 18.1M | 17.3M | 17.9M |
| Selling And Marketing Expenses | 26.3M | 24.5M | 23.5M | 23.6M | 23.0M | 21.6M | 20.6M | 20.3M |
| Selling General And Administrative Expenses | 47.3M | 44.0M | 41.4M | 41.4M | 40.4M | 39.6M | 37.8M | 38.2M |
| Other Expenses | 419K | 429K | 428K | 423K | 419K | 428K | 428K | 7.6M |
| Cost And Expenses | 90.1M | 84.5M | 83.7M | 83.9M | 82.0M | 81.3M | 79.1M | 90.5M |
| Interest Income | 2.1M | 2.1M | 2.2M | 2.4M | 2.7M | 3.1M | 3.5M | 3.8M |
| Interest Expense | 2.9M | 3.0M | 3.0M | 2.9M | 2.9M | 3.0M | 2.9M | 2.7M |
| Depreciation And Amortization | 3.8M | 4.2M | 4.4M | 4.5M | 3.2M | 4.4M | 4.6M | 5.0M |
| Ebitda | -14.4M | -6.4M | 16.9M | -18.1M | -29.6M | -26.3M | -24.6M | -38.5M |
| Ebitdaratio | -0.203 | -0.09 | 0.18 | -0.308 | -0.564 | -0.555 | -0.529 | -0.893 |
| Operating Income Ratio | -0.271 | -0.178 | 0.109 | -0.425 | -0.564 | -0.713 | -0.703 | -1.096 |
| Income Before Tax | -20.0M | -13.6M | 9.5M | -25.6M | -29.9M | -33.7M | -32.1M | -46.2M |
| Income Before Tax Ratio | -0.283 | -0.189 | 0.102 | -0.435 | -0.569 | -0.71 | -0.691 | -1.071 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.283 | -0.189 | 0.102 | -0.435 | -0.569 | -0.71 | -0.691 | -1.07 |
| Epsdiluted | -0.13 | -0.09 | 0.059 | -0.17 | -0.20 | -0.23 | -0.22 | -0.31 |
| Weighted Average Shs Out | 155.5M | 153.1M | 152.4M | 152.1M | 149.2M | 147.1M | 147.5M | 147.4M |
| Weighted Average Shs Out Dil | 155.5M | 153.1M | 163.2M | 152.1M | 149.2M | 147.1M | 147.5M | 147.4M |